The decision has been made to not renew our subscription to the PLOS flat fee publishing deal in 2025. This means that authors of outputs accepted for publication in a PLOS journal after the previous agreement end date of 31st December 2024 will be required to pay an open access article processing charge (APC).
Any authors who have already submitted an article to a PLOS journal which is still under consideration should contact openaccess@bournemouth.ac.uk immediately.
Authors who were considering publishing in a PLOS journal, but have not yet submitted their manuscript, should explore the seven other transformative agreements which BU is signed up to, which enable BU authors to publish open access for free or at a discounted rate. Authors that still wish to publish with a PLOS journal must apply to the open access publication fund before submission of their manuscript.
For all related enquiries, please email openaccess@bournemouth.ac.uk
Starting 1 April 2022, all BU corresponding authors will no longer need to pay the Article Processing Charge (APC) for publishing with PLOS Computational Biology, PLOS Digital Health, PLOS Genetics, PLOS Neglected Tropical Diseases, PLOS ONE and PLOS Pathogens, due to the JISC PLOS flat fee agreement that Bournemouth University has signed up to.











ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
First publication for two CMWH PhD students
Opportunities to support our REF preparations
SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease